Disparities in lung cancer staging with positron emission tomography in the cancer care outcomes research and surveillance (cancors) study

Journal of Thoracic Oncology

Volumn 6, Issue 5, 2011, Pages 875-883

  Gould, Michael K ^a,b,c   M Schultz, Ellen ^b   Wagner, Todd H ^a,d   Xu, Xiangyan ^e   Ghaus, Sharfun J ^a   Wallace, Robert B ^f   Provenzale, Dawn ^g   Au, David H ^h  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b STANFORD UNIVERSITY   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d Health Economics Resource Center   (United States)

^e Palo Alto Veterans Institute for Research   (United States)

^f UNIVERSITY OF IOWA   (United States)

^g DUKE UNIVERSITY   (United States)

^h UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Carcinoma; Emission computed; Healthcare disparities; Lung neoplasms; Neoplasm staging; Non small cell lung; Tomography

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CAUCASIAN; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED STUDY; EDUCATIONAL STATUS; ETHNICITY; FEMALE; HEALTH CARE DISPARITY; HEALTH CARE FACILITY; HIGH SCHOOL GRADUATE; HISPANIC; HUMAN; INCOME; INTEGRATED HEALTH CARE SYSTEM; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MEDICARE; MULTICENTER STUDY; OBSERVATIONAL STUDY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PRIVATE HEALTH INSURANCE;

EID: 79955431011     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e31821671b6     Document Type: Article

References (30)

1. Goldstraw P, Crowley J, Chansky K, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2007;2:706-714. (Pubitemid 47357522)
2. Groome PA, Bolejack V, Crowley JJ, et al. The IASLC Lung Cancer Staging Project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2007;2:694-705. (Pubitemid 47357521)
3. Spira A, Ettinger DS. Multidisciplinary management of lung cancer. N Engl J Med 2004;350:379-392. (Pubitemid 38101633)
4. Gould MK, Kuschner WG, Rydzak CE, et al. Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis. Ann Intern Med 2003;139:879-892.
5. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Non-Small Cell Lung Cancer; 2009. Available at: http://www.nccn.org/professionals/physician-gls/f-guidelines.asp. Accessed March 16, 2010.
6. Silvestri GA, Gould MK, Margolis ML, et al. Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest 2007;132(3 Suppl):178S-201S. (Pubitemid 47502807)
7. Fischer B, Lassen U, Mortensen J, et al. Preoperative staging of lung cancer with combined PET-CT. N Engl J Med 2009;361:32-39.
8. Maziak DE, Darling GE, Inculet RI, et al. Positron emission tomography in staging early lung cancer: a randomized trial. Ann Intern Med 2009;151:221-228, W-248.
9. van Tinteren H, Hoekstra OS, Smit EF, et al. Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial. Lancet 2002;359:1388-1393.
10. Committee on Comparative Effectiveness Prioritization. Initial National Priorities for Comparative Effectiveness Research. Washington, DC: Institute of Medicine of the National Academies, 2009.
11. Bach PB, Cramer LD, Warren JL, et al. Racial differences in the treatment of early-stage lung cancer. N Engl J Med 1999;341:1198-1205. (Pubitemid 29480659)
12. Wisnivesky JP, McGinn T, Henschke C, et al. Ethnic disparities in the treatment of stage I non-small cell lung cancer. Am J Respir Crit Care Med 2005;171:1158-1163. (Pubitemid 40663729)
13. Esnaola NF, Gebregziabher M, Knott K, et al. Underuse of surgical resection for localized, non-small cell lung cancer among whites and African Americans in South Carolina. Ann Thorac Surg 2008;86:220- 226; discussion 227.
14. Farjah F, Flum DR, Ramsey SD, et al. Multi-modality mediastinal staging for lung cancer among medicare beneficiaries. J Thorac Oncol 2009;4:355-363.
15. Ayanian JZ, Chrischilles EA, Fletcher RH, et al. Understanding cancer treatment and outcomes: the Cancer Care Outcomes Research and Surveillance Consortium. J Clin Oncol 2004;22:2992-2996.
16. Piccirillo JF. Importance of comorbidity in head and neck cancer. Laryngoscope 2000;110:593-602. (Pubitemid 30198711)
17. Piccirillo JF, Tierney RM, Costas I, et al. Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA 2004;291:2441-2447. (Pubitemid 38669187)
18. Zhang J, Yu KF. What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA 1998;280: 1690-1691. (Pubitemid 28532993)
19. Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol 1986;51:1173-1182.
20. Preacher KJ, Hayes AF. Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behav Res Methods 2008;40:879-891.
21. Woods LM, Rachet B, Coleman MP. Origins of socio-economic inequalities in cancer survival: a review. Ann Oncol 2006;17:5-19. (Pubitemid 43033834)
22. Halpern MT, Ward EM, Pavluck AL, et al. Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis. Lancet Oncol 2008;9:222-231.
23. Margolis ML, Christie JD, Silvestri GA, et al. Racial differences pertaining to a belief about lung cancer surgery: results of a multicenter survey. Ann Intern Med 2003;139:558-563.
24. Farjah F, Wood DE, Yanez ND III, et al. Racial disparities among patients with lung cancer who were recommended operative therapy. Arch Surg 2009;144:14-18.
25. Greenwald HP, Polissar NL, Borgatta EF, et al. Social factors, treatment, and survival in early-stage non-small cell lung cancer. Am J Public Health 1998;88:1681-1684. (Pubitemid 28499150)
26. Iezzoni LI, Ngo LH, Li D, et al. Treatment disparities for disabled medicare beneficiaries with stage I non-small cell lung cancer. Arch Phys Med Rehabil 2008;89:595-601. (Pubitemid 351406319)
27. Owonikoko TK, Ragin CC, Belani CP, et al. Lung cancer in elderly patients: an analysis of the surveillance, epidemiology, and end results database. J Clin Oncol 2007;25:5570-5577.
28. Lathan CS, Neville BA, Earle CC. The effect of race on invasive staging and surgery in non-small-cell lung cancer. J Clin Oncol 2006;24:413-418. (Pubitemid 46630461)
29. Suga JM, Nguyen DV, Mohammed SM, et al. Racial disparities on the use of invasive and noninvasive staging in patients with non-small cell lung cancer. J Thorac Oncol 2010;5:1772-1778.
30. Gould MK, Fletcher J, Iannettoni MD, et al. Evaluation of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007;132(3 Suppl): 108S-130S. (Pubitemid 47502803)